explore -WSS

explore

author：comprehensive 2025-09-27 16:48:33 - browse：71

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： AI can’t replace a physician’s gut feeling

entertainment

leisure time

WSS

Listen: Wegovy in the brain & pivotal Alzheimer's data

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Biden tests positive for Covid

Testing for cancer recurrence creates a new limbo for patients

At Orexo, a ‘turning point’ for everything but digital health

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Wikipedia

explore

explore

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare has a new plan to address drug shortages

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Traditional Chinese medicine benefits explored in new JAMA study

At least 13 dead in Texas as scorching temps continue

Emergency medicine has repudiated 'excited delirium.' Now what?

DIEP, the 'gold standard' of breast reconstruction, is under threat

At Orexo, a ‘turning point’ for everything but digital health

Continuity nursing helped my family in our darkest PICU moments

WHO calls for emergency meeting on new China virus, as cases spread

hotspot

Sanders adds drug shortage policies to pandemic preparedness bill

STAT Virtual Event: The State of Biosimilars: What to Watch

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Emergency medicine has repudiated 'excited delirium.' Now what?

Medicare has a new plan to address drug shortages

Traditional Chinese medicine benefits explored in new JAMA study

entertainment

leisure time

entertainment

explore